7.88BUSD
See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US9250501064
CUSIP
925050106
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
2.49
Dividend Share
-
Dividend Yield
-
Earnings Share
-2
Wall Street Target Price
100.00
EPS Estimate Current Year
1.18
EPS Estimate Next Year
-
EPS Estimate Current Quarter
-0.0325
EPS Estimate Next Quarter
-0.02
Most Recent Quarter
-
Revenue TTM
118,535,000
Gross Profit TTM
112,546,000
EBITDA
-133,641,000
Profit Margin
-138.31%
Return On Assets TTM
-20.64%
Return On Equity TTM
-72.61%
Revenue Per Share TTM
1.435
Qtly Revenue Growth YOY
0.00%
Diluted Eps TTM
-2
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
476
Price Sales TTM
66.6224
Price Book MRQ
34.9139
Enterprise Value Revenue
65
Enterprise Value EBITDA
-20
314.80
1.92%449.31
1.65%516.54
1.50%544.78
0.75%255.12
0.42%586.54
0.00%90.46
-3.20%190.02
-2.85%148.56
-1.54%78.18
-0.37%